Color Blindness Market Size, Epidemiology, Treatment, Top Companies, Drugs and Competitive Analysis by DelveInsight | EMAS Pharma, Janssen Research, applied genetic technologies and more


“Achromatopsia Market”

Achromatopsia is a condition characterized by a partial or complete absence of color vision. People with complete achromatopsia cannot perceive any color; they only see black, white and shades of gray. Incomplete color blindness is a milder form of the condition that allows some color discrimination.

by DelveInsight”Achromatopsia Market Overview, Epidemiology and Market Forecast-2030The report provides an in-depth understanding of achromatopsia, historical and forecast epidemiology as well as trends in the achromatopsia market in the United States, EU5 (Germany, Spain, Italy, France, and United Kingdom) and in Japan.

Some Key Facts of the Achromatopsia Market are:

  • Achromatopsia is a rare disease with an estimated prevalence of less than 1/30,000
  • Congenital forms of achromatopsia are considered stationary and do not worsen with age.
  • Visual acuity and eye movement stability usually improve over the first six to seven years of life – but remain close to 20/200.

Achromatopsia Report Scope

  • The report covers the descriptive overview of Achromatopsia, explaining its causes, signs and symptoms, pathophysiology, diagnosis and currently available therapies.
  • A comprehensive overview was provided on the epidemiology and treatment of achromatopsia in 7MM
  • Additionally, a comprehensive account of current and emerging therapies for color blindness is provided, along with the evaluation of new therapies, which will impact the current treatment landscape.
  • A detailed review of the Achromatopsia market; historical and forecast is included in the report, covering drug awareness in the 7MM
  • The report provides an edge when developing business strategies, by understanding the trends shaping and driving the global Achromatopsia market

Sample Report Request:

Achromatopsia also involves other vision problems, including increased sensitivity to light and glare (photophobia), involuntary back-and-forth eye movements (nystagmus), and significantly reduced visual acuity (low acuity visual). Affected individuals may also have farsightedness (farsightedness) or, less commonly, nearsightedness (myopia). These vision problems develop during the first months of life.

Achromatopsia companies covered:

  • EMAS Pharma
  • Janssen Research and Development
  • Applied Gene Technology Company
  • MeiraGTx UK II Ltd
  • Syne Qua not limited
  • And many more

Achromatopsia therapies:

  • AAV – CNGB3
  • AAV – CNGA3
  • AGTC-402
  • rAAV2tYF-PR1.7-hCNGB3
  • And many more

Sample Report Request:


1. Key information

2. Executive Summary of Achromatopsia

3. Competitive Intelligence Analysis for Achromatopsia

4. Color blindness: market overview at a glance

4.1. Total Achromatopsia Market Share (%) Distribution in 2017

4.2. Total Achromatopsia Market Share (%) Distribution in 2030

5. Achromatopsia: Background and overview of the disease

6. Patient journey

7. Epidemiology of achromatopsia and patient population

8. Treatment Algorithm, Current Treatment and Medical Practices

8.1. Treatment and management of color blindness

8.2. Achromatopsia treatment algorithm

9. Unmet Needs

10. Key Parameters of Achromatopsia Treatment

11. Marketed products

List to continue in the report

12. Emerging Therapies

List to continue in the report

13. Achromatopsia: seven main market analyzes

14. Attribute analysis

15. 7MM: Market Outlook

16. Colorblind Access and Reimbursement Overview

17. KOL Views

18. Market Drivers

19. Market Barriers

20. Appendix

21. DelveInsight Abilities

22. Disclaimer

About DelveInsight

DelveInsight is a leading business consulting and market research firm focused exclusively on life sciences. It supports pharmaceutical companies by providing complete end-to-end solutions to improve their performance. It also provides business advisory services with credible market analysis that will help accelerate business growth and overcome challenges with a hands-on approach.

Media Contact
Company Name: DelveInsight Business Research LLP
Contact: Ankit Nigam
E-mail: Send an email
Call: +19193216187
Address:304 S. Jones Boulevard #2432
City: Albany
State: New York
Country: United States


Comments are closed.